DANELLE SHAW: Open Payments
NPI 1922354141 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,438 in 39 payments from 11 companies in 2025. Trend: 2023 $2,691 · 2024 $3,510 · 2025 $3,438
Travel & lodging: $1,965Food & beverage: $1,473
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 4 | $1,923 |
| Boston Scientific Corporation | 13 | $1,089 |
| ABBVIE INC. | 5 | $109 |
| Collegium Pharmaceutical, Inc. | 6 | $106 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $69 |
| MML US, Inc. | 3 | $36 |
| SPR Therapeutics, Inc | 1 | $27 |
| Averitas Pharma Inc. | 1 | $24 |
| SI-BONE, INC. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: Evoke, Intracept, Belbuca, QULIPTA, UBRELVY, ReActiv8, SPRINT PNS System, QUTENZA.
Industry payments across NE — which companies pay providers there.
